Guardant Health Inc at UBS Genomics 2.0 and MedTech Innovations Summit Transcript
Great. Well, we're at the top of the hour here. Do we have Guardant on Zoom? They're not coming up right now. Great. Well, looking forward to getting started here on the next panel.
Again, for those who don't know me, I'm John Sourbeer on the life sciences team. And up here with me today, I have Mike Sarcone from the med tech team also helping out, and we're excited to be hosting Guardant Health. We have Helmy Eltoukhy, CEO; AmirAli Talasaz, also Co-CEO; and then Mike Bell, who is the CFO. All right. Welcome.
Questions & Answers
So maybe just to get things started off. During 2Q, Guardant Health made a unique leadership announcement with the structure of the co-CEOs. Can you talk a little bit about what led to that decision and how it will impact Guardant Health's operations on both oncology and screening and how do you think it will enable Guardant Health to more
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |